Re: Prevnar 13 vaccine Approved for Child Infections, become Pfizer’s top revenue generator

[Guest guest]

So now the percentage of pneumococcal serotypes available to flourish as

opportunistic infections is narrowed to 10%. That is, until Wyeth needs another

" lift " .

>

>

> Have we any doubt that large-N studies of vaccinated vs unvaccinated (re:

Prevnar 13) will be insisted upon by the FDA, HHS, and ACIP? After all, what's

more important, Pfizer revenues or vaccination safety?

>

>

>

> - - - -

>

> Vaccine Approved for Child Infections

>

> By DUFF WILSON

> February 24, 2010

> http://www.nytimes.com/2010/02/25/business/25vaccine.html

>

>

> The Food and Drug Administration on Wednesday approved Prevnar 13, an expanded

version of a vaccine to protect children against more forms of bacterial

infections that can cause meningitis, pneumonia and other diseases. Health

officials say such infections cause a million deaths a year in developing

countries and dozens of deaths in the United States, along with ear infections

in millions of infants.

>

> Prevnar 13, from the drug giant Pfizer, adds protection against six types of

bacteria to a current product, Prevnar 7, increasing its coverage to more than

90 percent of pneumococcal disease rather than the current product‚s 80 percent

coverage.

>

> Prevnar 7 had worldwide sales approaching $3 billion, making it one of the

Pfizer‚s best-selling drugs, and Credit Suisse analysts predict Prevnar 13 will

exceed $5 billion in sales by 2014. Pfizer is counting on it to become the

company‚s top revenue generator after its flagship drug, the cholesterol fighter

Lipitor, loses patent protection next year...

>

> http://www.nytimes.com/2010/02/25/business/25vaccine.html

>

>

>

> .

>

>

> Sheri Nakken, R.N., MA, Hahnemannian Homeopath

> Vaccination Information & Choice Network, Washington State, USA

> Vaccines - http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

> Vaccine Dangers, Childhood Disease Classes & Homeopathy Online/email courses -

next classes start February 24 & 25

>